Published in J Neural Transm (Vienna) on December 03, 2011
Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv (2015) 1.25
Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia. J Neuroinflammation (2014) 0.91
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev Neurother (2012) 0.89
Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies. J Psychiatr Res (2015) 0.85
Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity. Dev Cogn Neurosci (2014) 0.81
Cytokines and the neurodevelopmental basis of mental illness. Front Neurosci (2013) 0.81
Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.80
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis. Mol Psychiatry (2016) 0.79
Role of Inflammation in Suicide: From Mechanisms to Treatment. Neuropsychopharmacology (2016) 0.78
Effects of various phytochemicals on indoleamine 2,3-dioxygenase 1 activity: galanal is a novel, competitive inhibitor of the enzyme. PLoS One (2014) 0.76
Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase. Antimicrob Agents Chemother (2015) 0.75
Association between toll-like receptor 4 expression and symptoms of major depressive disorder. Neuropsychiatr Dis Treat (2015) 0.75
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 7.56
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry (1999) 5.63
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today (1999) 3.74
Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 3.00
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 2.79
The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci (2001) 2.61
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 2.36
Tryptophan and the immune response. Immunol Cell Biol (2003) 2.26
The macrophage theory of depression. Med Hypotheses (1991) 2.18
Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res (2006) 2.11
Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain (1992) 2.09
IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry (2005) 1.98
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia (2005) 1.93
Two mechanisms which increase in vivo the liver tryptophan peroxidase activity: specific enzyme adaptation and stimulation of the pituitary adrenal system. Br J Exp Pathol (1951) 1.89
Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet (1969) 1.80
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem (2001) 1.79
Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry (1999) 1.74
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol (1987) 1.65
Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord (2006) 1.58
3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem (1998) 1.58
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis (2004) 1.50
Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci (1998) 1.44
Increase in interleukin-1beta in late-life depression. Am J Psychiatry (2005) 1.40
Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses (2003) 1.37
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci (1995) 1.36
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32
Indicators of immune activation in major depression. Psychiatry Res (1996) 1.30
Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology (1999) 1.30
Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord (2005) 1.29
L-kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res (1980) 1.21
Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc Natl Acad Sci U S A (1986) 1.18
Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol (2001) 1.16
Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J Neurochem (1998) 1.13
Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord (2005) 1.09
The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry (2002) 1.08
The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes. Biochem J (1985) 1.05
Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am J Clin Nutr (1971) 1.02
Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. Redox Rep (2000) 0.99
Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology (2011) 0.98
The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood (1994) 0.97
Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem (1977) 0.96
Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med (1992) 0.96
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol (2001) 0.95
The "kynurenine shunt" and depression. Adv Biochem Psychopharmacol (1974) 0.89
Low natural killer cytotoxicity in major depression. Life Sci (1987) 0.89
Cytokines in major depression. Biol Psychiatry (1994) 0.88
Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci (2000) 0.87
Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism. Biochem Soc Trans (1985) 0.86
Stereospecificity of hepatic L-tryptophan 2,3-dioxygenase. Biochem J (1980) 0.85
Quinolinate neurotoxicity in cortical cell culture. Neuroscience (1987) 0.84
Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand (1992) 0.84
Effects on the diet on brain neurotransmitters. Metabolism (1977) 0.83
Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia. J Alzheimers Dis (2005) 0.83
Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage. J Neurosci Res (2008) 0.83
IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress. Redox Rep (2000) 0.82
Major depression and immunity: preliminary evidence of decreased natural killer cell populations. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.81
Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours. Clin Chem (1993) 0.81
COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection. Neurobiol Dis (2011) 0.78
Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs. Cell Tissue Res (1998) 0.78
[Synthesis and resolution of chiral ring-opened serotonin analogs of the 5-hydroxykynuramine type]. Pharm Acta Helv (1988) 0.75
Effects of a dietary excess of leucine and of the addition of leucine and 2-oxo-isocaproate on the metabolism of tryptophan and niacin in isolated rat liver cells. Br J Nutr (1989) 0.75
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Non-linearity and frequency shifts of nuclear magnetic spin-noise. J Magn Reson (2009) 1.37
Public stigma against people with mental illness in the Gilgel Gibe Field Research Center (GGFRC) in Southwest Ethiopia. PLoS One (2013) 1.36
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry (2002) 1.28
The identification of free-living environmental isolates of amoebae from Bulgaria. Parasitol Res (2004) 1.27
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
An ancestral secretory apparatus in the protozoan parasite Giardia intestinalis. J Biol Chem (2003) 1.23
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res (2010) 1.22
Immune System and Schizophrenia. Curr Immunol Rev (2010) 1.18
Signal enhancement in protein NMR using the spin-noise tuning optimum. J Biomol NMR (2010) 1.18
Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J Med Genet (2013) 1.16
Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis (2008) 1.13
Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther (2011) 1.12
Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry (2003) 1.08
Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite. Infect Immun (2003) 1.07
Observation of NMR noise from solid samples. J Magn Reson (2010) 1.07
Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray. PLoS Negl Trop Dis (2010) 1.07
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull (2008) 1.07
A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob Agents Chemother (2007) 1.06
Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis (2010) 1.05
Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis. J Clin Microbiol (2008) 1.05
In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob Agents Chemother (2006) 1.05
Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid Obsessive Compulsive Disorder. World J Biol Psychiatry (2004) 1.04
Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev Neurother (2006) 1.02
Isolation and molecular characterization of recombinant Echinococcus granulosus P29 protein (recP29) and its assessment for the post-surgical serological follow-up of human cystic echinococcosis in young patients. Trans R Soc Trop Med Hyg (2008) 1.01
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci (2008) 1.01
Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp Parasitol (2003) 0.98
Health-related quality of life in patients with Gilles de la Tourette's syndrome. Mov Disord (2010) 0.98
Intestinal Tritrichomonas foetus infection in cats in Switzerland detected by in vitro cultivation and PCR. Parasitol Res (2008) 0.98
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res (2003) 0.98
Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother (2007) 0.98
Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother (2008) 0.97
Tritrichomonas foetus isolates from cats and cattle show minor genetic differences in unrelated loci ITS-2 and EF-1α. Vet Parasitol (2011) 0.97
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci (2005) 0.97
Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. Int J Parasitol (2002) 0.97
Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol (2003) 0.97
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother (2011) 0.96
In vitro induction of Neospora caninum bradyzoites in vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites. Infect Immun (2004) 0.96
Screening of Swiss hot spring resorts for potentially pathogenic free-living amoebae. Exp Parasitol (2009) 0.95
PCR-based diagnosis of Naegleria sp. infection in formalin-fixed and paraffin-embedded brain sections. J Clin Microbiol (2006) 0.95
Ammonium ylides for the diastereoselective synthesis of glycidic amides. Chem Commun (Camb) (2010) 0.95
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur Arch Psychiatry Clin Neurosci (2004) 0.95
The association of infectious agents and schizophrenia. World J Biol Psychiatry (2010) 0.94
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res (2006) 0.94
COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des (2008) 0.93
Detection of Leishmania RNA virus in Leishmania parasites. PLoS Negl Trop Dis (2013) 0.93
Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res (2006) 0.93
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2004) 0.92
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.92
Non-linear signal detection improvement by radiation damping in single-pulse NMR spectra. Chemphyschem (2012) 0.92
Spin-Noise-Detected Two-Dimensional Fourier-Transform NMR Spectroscopy. J Phys Chem Lett (2013) 0.92
Inflammatory biomarkers and depression. Neurotox Res (2010) 0.92
Comparative study on the antioxidant and biological activities of carvacrol, thymol, and eugenol derivatives. J Agric Food Chem (2008) 0.92
In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob Agents Chemother (2005) 0.91
The first observation of Carbon-13 spin noise spectra. J Magn Reson (2012) 0.91
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull (2013) 0.91
Design, synthesis, and application of tartaric acid derived N-spiro quaternary ammonium salts as chiral phase-transfer catalysts. Org Biomol Chem (2011) 0.91
Long-term results of electroconvulsive therapy in severe Gilles de la Tourette syndrome. J ECT (2011) 0.91
The role of B- and T-cell immunity in toltrazuril-treated C57BL/6 WT, microMT and nude mice experimentally infected with Neospora caninum. Parasitol Res (2004) 0.90
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. Dialogues Clin Neurosci (2009) 0.90
Anti-inflammatory treatment in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
Interpreting conformational effects in protein nano-ESI-MS spectra. Anal Bioanal Chem (2003) 0.89
Asymmetric syntheses of three-membered heterocycles using chiral amide-based ammonium ylides. Org Biomol Chem (2015) 0.89
Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry (2005) 0.88
Hepatic gene expression profile in mice perorally infected with Echinococcus multilocularis eggs. PLoS One (2010) 0.88
Cost of illness in patients with Gilles de la Tourette's syndrome. J Neurol (2010) 0.88
Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatr Dis Treat (2007) 0.87
Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2). J Antimicrob Chemother (2013) 0.87
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. J Psychiatr Res (2008) 0.87
Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene. Brain Behav Immun (2013) 0.87
Therapy-refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulation. Mov Disord (2008) 0.87
On the tuning of high-resolution NMR probes. Chemphyschem (2014) 0.87
Inflammation in schizophrenia. Adv Protein Chem Struct Biol (2012) 0.87
Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. J Immunother (2007) 0.86
Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. Int J Parasitol (2006) 0.86
Apparatus for rapid adjustment of the degree of alignment of NMR samples in aqueous media: verification with residual quadrupolar splittings in (23)Na and (133)Cs spectra. J Magn Reson (2006) 0.86
Impaired monocyte activation in schizophrenia. Psychiatry Res (2012) 0.86
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance. Cardiovasc Psychiatry Neurol (2010) 0.86
Functional outcome and quality of life in Tourette's syndrome after deep brain stimulation of the posteroventrolateral globus pallidus internus: long-term follow-up. World J Biol Psychiatry (2013) 0.86
Intraperitoneal Echinococcus multilocularis infection in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development. Parasitol Int (2010) 0.86
Cytomegalovirus and schizophrenia. CNS Drugs (2006) 0.86
Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients. Inflammopharmacology (2012) 0.86
Proisocrinins A-F, brominated anthraquinone pigments from the stalked crinoid Proisocrinus ruberrimus. J Nat Prod (2009) 0.86
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6. Eur Arch Psychiatry Clin Neurosci (2012) 0.85
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. Curr Pharm Des (2011) 0.85
Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides. Exp Parasitol (2007) 0.85
Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers. Eur Arch Psychiatry Clin Neurosci (2014) 0.85
Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis (2007) 0.85
Comparative analysis of Tritrichomonas foetus (Riedmüller, 1928) cat genotype, T. foetus (Riedmüller, 1928) cattle genotype and Tritrichomonas suis (Davaine, 1875) at 10 DNA loci. Int J Parasitol (2012) 0.85
Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions. Int J Parasitol (2010) 0.85
An intact laminated layer is important for the establishment of secondary Echinococcus multilocularis infection. Parasitol Res (2002) 0.85